Ascendis Pharma A/S
NASDAQAscendis Pharma reports Q3 results on September 4 with the Street firmly bullish but modestly dialling back expectations — while short interest has quietly built to its highest level in six weeks. The analyst picture has shifted slightly since the previous note. Oppenheimer's Leland Gershell moved in the opposite direction on Wednesday, raising his target to $312 from $304 while…
ASND short interest surges 20.8% in one week to 1.99M shares, driven by biotech sector volatility and competitive pressures in endocrinology therapeutics.
Ascendis Pharma reports Q3 results on September 4 with the Street firmly bullish but modestly dialling back expectations — while short interest has quietly built to its highest level in six weeks. The analyst picture…
Ascendis Pharma heads into its September 4 earnings report with the analyst community firmly in the buy camp — but quietly marking down price targets even as the stock jumps. The most striking development since the…
Snapshot as of 20 Sept 2026
Ascendis Pharma heads into its September 4 earnings date with options markets flashing an unusual degree of caution even as the stock trades quietly near flat on the month. The clearest tension this week sits in the…
Ascendis Pharma closed Friday at $260.75, up 13% on the week, marking its strongest seven-day stretch in months — yet the rally is colliding with a notable shift in the short book and a Street that remains divided on…
Ascendis Pharma reports Q1 2026 results today against a backdrop of strengthening short-side sentiment — but options traders are firmly in the bull camp. The standout signal heading into the print is the options…
Ascendis Pharma enters its Q1 2026 earnings call — scheduled for tomorrow, May 7 — with its ORTEX short score having nearly doubled over the past two weeks, setting up one of the more charged pre-earnings positioning…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ASND — free to start on ORTEX.
Sign up for free →Open ASND on ORTEX